Moderate riskFDA DrugClass II

Amgen Sensipar cinacalcet tablets recalled for CGMP deviations

Amgen is recalling Sensipar (cinacalcet) 60mg tablets due to deviations from manufacturing standards. The recall affects one lot (1157055) with an expiration date of January 31, 2028, distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have Sensipar lot #1157055 (expiration 1/31/2028).
  2. Do not stop taking your medication without consulting your doctor.
  3. Contact your pharmacy or Amgen for instructions on replacement or verification.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 5 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
1 Amgen Center Dr, N/A, Thousand Oaks, CA, United States
Classification
Class II
Recall number
D-0614-2026

In the FDA's words

Description
Sensipar (cinacalcet) Tablets, 60mg, 30-count bottles, Rx Only, Distributed by: Amge, One Amgen Center Drive, Thousand Oaks ,CA 91320-1799, Made in Japan. NDC 55513-074-30 CGMP Deviations Lot #: 1157055, Exp. Date 1/31/2028 Distribution: Nationwide within the United States Affected quantity: N/A
Hazard
CGMP Deviations

5 products in this recall

Amgen Corlanor and Sensipar tablets recalled for foreign substance

Amgen is recalling five bottle sizes of two prescription heart and thyroid-related drugs, Corlanor (ivabradine) and Sensipar (cinacalcet), because the tablets may contain a foreign substance. The products were distributed nationwide, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

OtherDrugsSold nationwideMore from FDA Drug